Agricultural Biotechnology Market (By Application: Vaccine Development, Transgenic Crops & Animals, Antibiotic Development, Nutritional Supplements, Flower Culturing, Biofuels; By Organism Type: Plants, Animals, Microbes; By Type: Hybrid Seeds, Transgenic Crops, Bio-pesticides, Bio-fertilizers; By Technology: Genetic Engineering, Tissue Culture, Embryo Rescue, Somatic Hybridization, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Agricultural Biotechnology Market
5.1. COVID-19 Landscape: Agricultural Biotechnology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Agricultural Biotechnology Market, By Application
8.1. Agricultural Biotechnology Market, by Application, 2024-2034
8.1.1. Vaccine Development
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Transgenic Crops & Animals
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Antibiotic Development
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Nutritional Supplements
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Flower Culturing
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Biofuels
8.1.6.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Agricultural Biotechnology Market, By Organism Type
9.1. Agricultural Biotechnology Market, by Organism Type, 2024-2034
9.1.1. Plants
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Animals
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Microbes
9.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Agricultural Biotechnology Market, By Type
10.1. Agricultural Biotechnology Market, by Type, 2024-2034
10.1.1. Hybrid Seeds
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Transgenic Crops
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Bio-pesticides
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Bio-fertilizers
10.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Agricultural Biotechnology Market, By Technology
11.1. Agricultural Biotechnology Market, by Technology, 2024-2034
11.1.1. Genetic Engineering
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Tissue Culture
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Embryo Rescue
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Somatic Hybridization
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Molecular Diagnostics
11.1.5.1. Market Revenue and Forecast (2021-2034)
11.1.6. Vaccine
11.1.6.1. Market Revenue and Forecast (2021-2034)
11.1.7. Others
11.1.7.1. Market Revenue and Forecast (2021-2034)
Chapter 12. Global Agricultural Biotechnology Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Application (2021-2034)
12.1.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.1.3. Market Revenue and Forecast, by Type (2021-2034)
12.1.4. Market Revenue and Forecast, by Technology (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Application (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Type (2021-2034)
12.1.5.4. Market Revenue and Forecast, by Technology (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Application (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Type (2021-2034)
12.1.6.4. Market Revenue and Forecast, by Technology (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Application (2021-2034)
12.2.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.2.3. Market Revenue and Forecast, by Type (2021-2034)
12.2.4. Market Revenue and Forecast, by Technology (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Application (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Type (2021-2034)
12.2.5.4. Market Revenue and Forecast, by Technology (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Application (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Type (2021-2034)
12.2.6.4. Market Revenue and Forecast, by Technology (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Application (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Type (2021-2034)
12.2.7.4. Market Revenue and Forecast, by Technology (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Application (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Type (2021-2034)
12.2.8.4. Market Revenue and Forecast, by Technology (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Application (2021-2034)
12.3.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.3.3. Market Revenue and Forecast, by Type (2021-2034)
12.3.4. Market Revenue and Forecast, by Technology (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Application (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Type (2021-2034)
12.3.5.4. Market Revenue and Forecast, by Technology (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Application (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Type (2021-2034)
12.3.6.4. Market Revenue and Forecast, by Technology (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Application (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Type (2021-2034)
12.3.7.4. Market Revenue and Forecast, by Technology (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Application (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Type (2021-2034)
12.3.8.4. Market Revenue and Forecast, by Technology (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Application (2021-2034)
12.4.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.4.3. Market Revenue and Forecast, by Type (2021-2034)
12.4.4. Market Revenue and Forecast, by Technology (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Application (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Type (2021-2034)
12.4.5.4. Market Revenue and Forecast, by Technology (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Application (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Type (2021-2034)
12.4.6.4. Market Revenue and Forecast, by Technology (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Application (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Type (2021-2034)
12.4.7.4. Market Revenue and Forecast, by Technology (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Application (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Type (2021-2034)
12.4.8.4. Market Revenue and Forecast, by Technology (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Application (2021-2034)
12.5.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.5.3. Market Revenue and Forecast, by Type (2021-2034)
12.5.4. Market Revenue and Forecast, by Technology (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Application (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Type (2021-2034)
12.5.5.4. Market Revenue and Forecast, by Technology (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Application (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Organism Type (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Type (2021-2034)
12.5.6.4. Market Revenue and Forecast, by Technology (2021-2034)
Chapter 13. Company Profiles
13.1. ADAMA Ltd
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bayer AG
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. ChemChina
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Corteva
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Evogene Ltd.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. KWS SAAT SE & Co. KGaA
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Limagrain
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Marrone Bio Innovations
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. MITSUI & CO., LTD
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Nufarm
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client